|
NEU3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86180000305569E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.6409000000015E-05 |
| Normal-vs-Stage2 |
3.204300E-03 |
| Normal-vs-Stage3 |
3.70800000037974E-07 |
| Normal-vs-Stage4 |
4.64429994462279E-09 |
| Stage1-vs-Stage2 |
7.195800E-01 |
| Stage1-vs-Stage3 |
5.703600E-02 |
| Stage1-vs-Stage4 |
7.936200E-03 |
| Stage2-vs-Stage3 |
3.445200E-01 |
| Stage2-vs-Stage4 |
9.200100E-02 |
| Stage3-vs-Stage4 |
4.109600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.13339999607831E-08 |
| Normal-vs-AfricanAmerican |
5.879400E-03 |
| Normal-vs-Asian |
8.040800E-01 |
| Caucasian-vs-AfricanAmerican |
9.064000E-01 |
| Caucasian-vs-Asian |
9.456400E-02 |
| AfricanAmerican-vs-Asian |
2.075200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44539999968885E-07 |
| Normal-vs-Female |
2.93729999989445E-07 |
| Male-vs-Female |
8.419600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.86799999996246E-06 |
| Normal-vs-Age(41-60Yrs) |
1.163120E-04 |
| Normal-vs-Age(61-80Yrs) |
3.88910004200937E-09 |
| Normal-vs-Age(81-100Yrs) |
4.016000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.694300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.569200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.893000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.784100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.026400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.485800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.603200E-01 |
| Normal-vs-Grade 2 |
1.81800000054189E-07 |
| Normal-vs-Grade 3 |
2.40239999999003E-05 |
| Normal-vs-Grade 4 |
2.8346000002788E-07 |
| Grade 1-vs-Grade 2 |
1.660440E-01 |
| Grade 1-vs-Grade 3 |
3.325000E-01 |
| Grade 1-vs-Grade 4 |
5.837900E-02 |
| Grade 2-vs-Grade 3 |
7.032000E-01 |
| Grade 2-vs-Grade 4 |
8.795600E-02 |
| Grade 3-vs-Grade 4 |
9.947900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.4846999999939E-05 |
| Normal-vs-ccB subtype |
4.13670000000144E-05 |
| ccA subtype-vs-ccB subtype |
8.135200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93439999995881E-06 |
| Normal-vs-N1 |
1.283640E-01 |
| N0-vs-N1 |
8.138200E-01 |
|
|
